Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    16314626 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Study of Cetuximab in Nasopharyngeal Carcinoma (NPC) With Chemoradiotherapy
Condition: Nasopharyngeal Carcinoma
Intervention: Drug: C225 (cetuximab)
2 Completed Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
Condition: Head and Neck Cancer
Interventions: Biological: cetuximab;   Drug: cisplatin

Indicates status has not been verified in more than two years